Plain-English translation of NCT06957366 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the best strategy for managing patients who take a blood thinner called a DOAC (direct oral anticoagulant) and need major surgery or a procedure that uses spinal anesthesia. Doctors currently aren't sure whether patients should simply stop the medication a few days before surgery, or if they need additional blood-thinning medications or special testing. This study will help answer that question.
Thousands of patients each year take these blood thinners to prevent serious blood clots and strokes, but the safest way to manage them before high-risk surgery is unclear. Current guidelines don't have strong answers because there hasn't been enough high-quality research, so doctors and patients need better guidance.
You likely qualify if…
You likely don't qualify if…
If you enroll, your doctor will decide which approach to use for managing your blood thinner around your surgery—either the simple approach of stopping it for a few days before and after, or another strategy being tested. You'll need to stay in contact with the research team during your surgery and recovery period so they can track how you're doing and watch for any bleeding problems or blood clots. The study is comparing different approaches to see which one is safest.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
United States